To view on-demand, please fill our short form

*
Captcha

While there are over > 6,000 R&D biologic pipeline programs1, only 7.9% of early-stage candidates get their drugs approved and it takes, on average, 10.5 years to move from Phase 1 to approval2. Emerging and smaller companies are often at a disadvantage to larger, established companies, taking >2 years longer to get to market3.

Regardless of a company’s size, recognizing the importance of packaging development and prioritizing its role in drug development early on can help you proactively identify events that could delay your timelines and prepare you to develop strategies to overcome these risks. This webinar will focus on challenges that emerging biologic companies face early on in drug development and decisions you can make to mitigate delays and risks.

This webinar will help you:

  • Recognize important elements to consider when choosing primary packaging
  • Prepare for changing regulations such as EU GMP Annex 1
  • Scale up from concept, through clinical to commercial 
  • Plan for success through containment solutions and services to reduce the risk for slowdowns in time to market

If you work for a startup or emerging company and are in the process of developing a complex or sensitive injectable drug, don’t miss this opportunity to learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

Sources:

Pharmacircle, Biologic Molecules, Phase 1-3, Injectable formats, accessed September 16, 2024Clinical Development Success Rates and Contributing Factors 2011–2020. February 2021. Prepared by BIO, Informa Pharma Intelligence, and QLS Advisors.

Emerging Biopharma’s Contribution to Innovation, June 2022, IQVIA

Deolinda Izumida Martins, Ph.D., MBA

Technical Account Manager, TCS

Deolinda has been working as Technical Account Manager at West since 2014. She graduated with a degree in Pharmacy, has a Master of Sciences in Toxicology and a Ph.D. in Public Health. Deolinda is experienced in technical consulting services with a demonstrated history of working in the pharmaceuticals industry and a scientific background in pharma primary packaging, analytical chemistry, and toxicology. In 2022 she was recognized with “Woman in Life Sciences” award by PDA Brazil chapter for her contribution to science and education.

James Lee

Technical Account Specialist

James is a Technical Account Specialist at West, a role he has held since 2021. He earned his B.S. in Chemistry from Roanoke College. James has experience in Technical Service and Product Development within the polymer and chemical industries. His scientific background includes pharmaceutical primary packaging, analytical testing, and material science.